• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Well tolerated solid or liquid pharmaceutical compound is a combination of African plants with synergistic actions to improve the health of people living with HIV, it is a combination of five plants that are: Imperata cylindrica roots, roots and leaves of moringa oleifeira, roots of paspalum conjugatum, and xanthoxyloid Fagara roots and roots of cyathea aethiopica. This product is obtained by first drying these different roots and seeds in the shade. Then they are crushed, sieved to obtain a fine powder. The various powders are mixed and distributed in empty capsules that have been thoroughly cleaned and put in small bottles of 20, 50 or 100 capsules. Solid pharmaceutical compound may be more concentrated and then supplemented with a solvent. Then each vial is placed in a suitable device for about a week. The enriched powders obtained are mixed using a mixer-mixer. These capsules can even be blistered. The liquid form The different powders are weighed and taken in appropriate quantities, the mixture is made in a large container, and then a solvent is added. The solid and liquid pharmaceutical compound has an antiviral, antibacterial and immune system stimulating action.
    公开号:FR3021224A1
    申请号:FR1401199
    申请日:2014-05-26
    公开日:2015-11-27
    发明作者:Henri Charles Ainadou
    申请人:Henri Charles Ainadou；
    IPC主号:
    专利说明:

    [0001] The present invention relates to a solid or liquid phytomedicine useful for the health of persons living with HIV, acting as a powerful antiviral, an immune system stimulant and an antibacterial against opportunistic diseases. HIV is a viral disease that creates a significant deficit in the immune system that opens the door to all sorts of opportunistic infections. Today antiretrovirals are an important arsenal in the HIV management system. Alongside these drugs, phytotherapy occupies a place of choice and allows those in Africa who do not have access to antiretrovirals to get by.
    [0002] The medicinal plants used to reduce the disorders related to the acquired immunodeficiency are numerous. People who have medicinal plants in their cultural heritage that are useful for the treatment of disorders linked to immune deficiency use the latter without any scientific rigor. This does not protect them completely or against the disease or other health problems (kidney, spleen, toxic effect) The present invention makes it possible to remedy the decline in immunity and effectively fight against opportunistic diseases . The solid or liquid pharmaceutical compound, a rigorously selected and tested herbal medicine has a dual role namely, to improve the immune system and effectively fight against opportunistic diseases.
    [0003] The solid or liquid pharmaceutical compound that comes to solve these various problems and complications, is an effective drug in the improvement of the immune system but is also used effectively for healing when opportunistic diseases are installed. According to a first aspect of the invention, it is in the form of a capsule comprising an association of four plants, namely: Total extracts of plants of the family Gramineae, of the genus Imperata, more particularly of the species Imperata cylindrica, total extracts of plants of the family of grasses of a genus paspalum, more particularly of the species paspalum conjugatum, total extracts of plants of the moringaceae family, of a moringa genus, more particularly of the species moringa oléifeira. Total extracts of plants of the rutaceae family of a fagara genus, more particularly of the fagara Xanthoxyloïdes species, total extracts of plants of the pteridophyte family of genus cyathea, more particularly of the species cyathea aethiopica. Solid Form Thus, in solid form, the pharmaceutical compound can be obtained by drying these different roots and seeds in the first place in the shade. Then they are crushed, sieved to obtain a fine powder. The different powders are weighed, taken in defined proportions, they are mixed and distributed in empty capsules previously well preserved and put in small bottles of 20, 50 or 100 capsules. The solid phytomedicament can according to another scientific method have a more concentrated appearance: to do this we must weigh each powder to put in a suitable solvent. Then each bottle is placed in a device called "rotavapor", which is allowed to rotate for a week or so. It is used for the enrichment and concentration of active ingredients. This makes the product more efficient. Mixing is carried out with an apparatus called mixer-kneader for a more rigorous mixture and the powders are distributed in the capsules. These capsules may be blistered and excipients may be used at this level. The liquid form According to another aspect of the invention, there is provided a solution of the compound; the various powders taken in appropriate quantities, the mixture is made in a large stainless steel container, then is added 40 ° ethyl alcohol or Royal Gin at a rate of 100g of powder per liter of alcohol. The mixture is made using a spatula or ladle and is filtered and then distributed in the flasks. The solid and liquid pharmaceutical compound has an antiviral, antibacterial and stimulating action of the immune system. INDICATIONS: Improves the health of people living with HIV DOSAGE Capsules: 2 capsules morning and evening in the middle of meals Solution: one tablespoon morning and evening in the middle of meals Precaution for use: Kidney failure PRESENTATION In capsules box of 50, of 100 and in box of 20.
    [0004] In 1 liter bottle solution and in 250 ml bottle.
    权利要求:
    Claims (4)
    [0001]
    CLAIMS1-Pharmaceutical compound for persons living with HIV comprising: Total extracts of plants of the family Gramineae, of the genus Imperata, more particularly of the species Imperata cylindrica, total extracts of plants of the family of grasses particularly of the species paspalum conjugatum, Total extracts of plants of the family Moringaceae, particularly of the species moringa oléifeira. Total extracts of plants of the family of the species particularly fagara Xanthoxyloids, total extracts of plants of the family of pteridophytes of a particular species cyathea aethiopica;
    [0002]
    2-Pharmaceutical compound according to claim 1 characterized in that in solid form, it can be obtained by drying the different roots and seeds in the shade, they are then crushed, sieved, taken in defined proportions, they are mixed and distributed in capsules and placed in bottles of 20, 50 or 100 capsules.
    [0003]
    3-Pharmaceutical compound according to claims 1 and 2 characterized in that in more concentrated form, the various powders in a given solvent, each vial is placed in a suitable apparatus that is allowed to rotate for a week or so, for the concentration of active subtances. More rigorous mixing of the powders and distribution into capsules, which can even be blistered, excipients can be used.
    [0004]
    4-Pharmaceutical compound according to claims 1 and 2 characterized in that in liquid form, the various powders taken in defined proportions, mixing is carried out with a solvent in a container. of a genus paspalum, more of a genus moringa, more rutaceous of a genus fagara, more genus cyathea, more
    类似技术:
    公开号 | 公开日 | 专利标题
    George2011|Concerns regarding the safety and toxicity of medicinal plants-An overview
    Willcox et al.2004|Traditional medicinal plants and malaria
    FR3021224A1|2015-11-27|PHYTOMEDICAMENT FOR HIV
    Ernest et al.2011|Effect of aqueous extract of Chrysophyllum cainito leaves on the glycaemia of diabetic rabbits
    CN101132698A|2008-02-27|Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
    Rahmatullah et al.2012|Medicinal plants used by various tribes of Bangladesh for treatment of malaria
    Talakal et al.1995|In vitro and in vivo antitrypanosomal activity of Xanthium strumarium leaves
    US20130101627A1|2013-04-25|Composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions
    Asgarpanah et al.2015|An overview on phytopharmacology of Pelargonium graveolens L.
    Imanirampa et al.2016|Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: an in vitro evaluation
    Al Mamun et al.2015|Flavonoids isolated from Tridax procumbens | inhibit osteoclasts differentiation and bone resorption
    Flagg2021|Traditional and current use of ginseng
    Dvorkin-Camiel et al.2008|Tropical American plants in the treatment of infectious diseases
    Jones1995|Pau d'Arco: Immune power from the rain forest
    Koffi et al.2014|Evaluation of Picralima nitida acute toxicity in the mouse
    Standard2016|Natural Standard Herb & Supplement Guide-E-Book: An Evidence-Based Reference
    KR100262072B1|2000-07-15|Methods of extraction and purification from polygalae radix and natural compounds including its extracts
    FR3021222A1|2015-11-27|PHYTOMEDICAMENT AGAINST MALARIA
    RU2315616C1|2008-01-27|Agent for treatment and prophylaxis of cardiovascular diseases
    FR3080283A1|2019-10-25|PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST FIEVRE LASSA
    FR3080282A1|2019-10-25|PHYTOMEDICAMENT WITH ANTIBACTERIAL ACTIVITY AGAINST GASTRODUODENAL ULCER AND CROHN'S DISEASE
    FR3080280A1|2019-10-25|PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST EBOLA FEVER
    Rasoanaivo et al.2018|Using Appropriate Methodology and Technology for Research and Development of African Traditional Medicines
    Denis-Esdras et al.2017|Ethnobotany study of Loranthaceae, hemiparasitic plants used in traditional medicine by population, in the Sud-Comoé region |
    FR3080281A1|2019-10-25|PHYTOMEDICAMENT WITH ANTIVIRAL ACTIVITY AGAINST VIRAL HEPATITIS
    同族专利:
    公开号 | 公开日
    FR3021224B1|2017-11-17|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    FR2855056A1|2002-01-18|2004-11-26|Fagla Jerome Medegan|Herbal medicament, e.g. for treating sickle cell anemia or AIDS, containing extracts of Fagara xanthyloxyloides and Securidaca longepedonculata and/or Uvaria chamae|
    FR2859107A1|2003-08-26|2005-03-04|Oyoubi Pierre Pyebi|USE OF THE EXTRACTS OF A GRAMINEE, A RUTACEE AND A PIERIDOPHYTE IN A PHARMACEUTICAL COMPOSITION WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL ACTIVITY AND ALSO INTENDED TO STIMULATE IMMUNE DEFENSES|CN108355081A|2018-03-27|2018-08-03|江苏娘亲亲母婴健康管理有限公司|A kind of Chinese medicine preparation of immune promotion|
    FR3080280A1|2018-04-19|2019-10-25|Henri Charles Ainadou|PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST EBOLA FEVER|
    FR3080283A1|2018-04-19|2019-10-25|Henri Charles Ainadou|PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST FIEVRE LASSA|
    FR3080281A1|2018-04-19|2019-10-25|Henri Charles Ainadou|PHYTOMEDICAMENT WITH ANTIVIRAL ACTIVITY AGAINST VIRAL HEPATITIS|
    法律状态:
    2015-06-24| PLFP| Fee payment|Year of fee payment: 2 |
    2015-11-27| PLSC| Publication of the preliminary search report|Effective date: 20151127 |
    2016-04-06| PLFP| Fee payment|Year of fee payment: 3 |
    2016-09-07| PLFP| Fee payment|Year of fee payment: 4 |
    2017-11-23| PLFP| Fee payment|Year of fee payment: 5 |
    2019-10-04| PLFP| Fee payment|Year of fee payment: 7 |
    2022-02-11| ST| Notification of lapse|Effective date: 20220105 |
    优先权:
    申请号 | 申请日 | 专利标题
    FR1401199A|FR3021224B1|2014-05-26|2014-05-26|PHYTOMEDICAMENT FOR HIV|FR1401199A| FR3021224B1|2014-05-26|2014-05-26|PHYTOMEDICAMENT FOR HIV|
    [返回顶部]